Cargando…
New Anti-CGRP Medications in the Treatment of Vestibular Migraine
BACKGROUND: Vestibular migraine (VM) is a condition associated with migraine headache, vertigo, dizziness, and balance disturbances. Treatment options are limited. It is unknown if new calcitonin gene-related peptide (CGRP) migraine medications have efficacy in treating VM. METHODS: We retrospective...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828914/ https://www.ncbi.nlm.nih.gov/pubmed/35153979 http://dx.doi.org/10.3389/fneur.2021.799002 |